AC

Ankush Cheema

Active Director Director DIN 09265808
DIN 09265808 First appointment Aug 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Ankush Cheema

Data last updated:

Ankush Cheema is a Director at Ubix Bioscience Private Limited (since 2021). The company operates in Pharma. Ubix Bioscience Private Limited reported revenue of ₹1.86 Cr (FY 2024).

DIN 09265808
Primary Designation Director
Industry Pharma
First Appointment 03 Aug 2021
Oldest Company Age 5 yrs
Largest company Ubix Bioscience Private Limited · ₹1.86 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ubix Bioscience Private Limited U51909UR2021PTC012427
Director03 Aug 20212021₹1.86 Cr (FY 2024)Active

Board colleagues of Ankush Cheema

NameDINCompanyDesignation
Shailu Singh09034768Ubix Bioscience Private LimitedDirector
Ubraj Singh06397107Ubix Bioscience Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ubix Bioscience Private Limited
Premium access

Shareholding and investment profile for Ankush Cheema

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankush Cheema

Ankush Cheema currently holds 1 directorship: Ubix Bioscience Private Limited (Director, since 03 Aug 2021, revenue ₹1.86 Cr (FY 2024)).

Ankush Cheema was first appointed on 03 Aug 2021 as Director at Ubix Bioscience Private Limited.

The current boards of Ankush Cheema's companies include Shailu Singh (Ubix Bioscience Private Limited), Ubraj Singh (Ubix Bioscience Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available